Your session is about to expire
← Back to Search
Emotional Processes and Speech Control for Stuttering
N/A
Recruiting
Led By Victoria Tumanova, PhD
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No history of neurological diseases or diagnosed speech-language disorders apart from stuttering.
Parent report or direct observation of oral-facial structural abnormalities (such as cleft lip and/or cleft palate).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 3 weeks
Awards & highlights
Summary
This trial will compare speech patterns of children who stutter with those of fluent peers, to better understand the development of stuttering.
Who is the study for?
This trial is for preschool-age children who stutter but do not have other speech-language disorders, neurological diseases, or oral-facial structural abnormalities like cleft lip/palate. They should be primarily English speakers with normal hearing and vision (with glasses if needed), and not on medications affecting neural functions.Check my eligibility
What is being tested?
The study tests how viewing pictures that are emotionally charged (negative) versus neutral affects speech motor control in children who stutter compared to those who don't. It aims to understand the interaction between emotion and speech variability in early childhood stuttering.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures such as speaking after viewing images, there are no direct medical side effects expected from participating in this research.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have no neurological diseases or speech disorders, except for stuttering.
Select...
I have a cleft lip/palate or similar facial abnormality.
Select...
My hearing is normal.
Select...
I am not taking any medications that affect brain function.
Select...
I have no neurological diseases or speech disorders, except for stuttering.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The spatiotemporal index (STI) of lip aperture during a negative valence condition on Day 1 (pretest).
The spatiotemporal index (STI) of lip aperture during a negative valence condition on Day 2 (retention).
The spatiotemporal index (STI) of lip aperture during a neutral valence condition on Day 1 (pretest).
+1 moreSecondary outcome measures
Executive function (EF) composite score
Number of phasic skin conductance responses elicited by picture presentations
Respiratory sinus arrhythmia (RSA)
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Experimental ConditionExperimental Treatment1 Intervention
Speaking while viewing images with negative and neutral valence
Find a Location
Who is running the clinical trial?
Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,560 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
339 Previous Clinical Trials
179,695 Total Patients Enrolled
9 Trials studying Stuttering
6,261 Patients Enrolled for Stuttering
Victoria Tumanova, PhDPrincipal InvestigatorSyracuse University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have normal vision according to what your parent says.I have a cleft lip/palate or similar facial abnormality.The participant's parents have reported that the participant has a neurodevelopmental disorder like autism.The participant has vision problems that are not fixed with glasses.Your parent or someone else has noticed that your mouth or face has an abnormal shape, like a cleft lip or palate.My hearing is normal.I am not taking any medications that affect brain function.I have no neurological diseases or speech disorders, except for stuttering.I have no neurological diseases or speech disorders, except for stuttering.Your parents say you have good vision.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Stuttering Patient Testimony for trial: Trial Name: NCT05003583 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger